Business Combination - In-Process R&D (IPR&D) Capitalized as Indefinite-Lived Intangible
Recognizing acquired in-process research and development (IPR&D) as a separate indefinite-lived intangible asset at fair value on the acquisition date — not expensed, unlike internally generated R&D costs.
| Account Name | Type | Debit ($) | Credit ($) |
|---|---|---|---|
| IPR&D Intangible Asset (Indefinite-Lived at Acquisition) | Asset (+) | 28,000,000.00 | - |
| Net Assets / PPA (Absorbed in Acquisition Entry) | Reference Entry | - | 28,000,000.00 |
💡 Accountant's Note
This is one of the most counterintuitive aspects of business combination accounting. When a company internally spends on R&D, ASC 730 requires immediate expensing. But when a company ACQUIRES a business and that business has ongoing R&D projects, the acquired IPR&D is CAPITALIZED as an indefinite-lived intangible at fair value on the acquisition date (ASC 805-20-25-15). The logic: the acquired IPR&D has met the recognition criteria (identifiable, separable, probable future benefit) — unlike internal R&D (where future benefit is uncertain). The IPR&D sits as an indefinite-lived intangible (no amortization, annual impairment test) UNTIL the project is completed (at which point it becomes a finite-lived intangible and is amortized) or abandoned (at which point it is written off immediately).
Practitioner & Systems Framework
💻 ERP Architecture
Track each IPR&D project separately. Set up a separate GL account for IPR&D intangibles. At each reporting period: (1) test for impairment if indicators exist, (2) assess project status (still in progress → remain indefinite-lived; completed → reclassify to finite-lived and begin amortizing; abandoned → write off). The fair value of IPR&D uses a multi-period excess earnings method (MPEEM) or relief from royalty method — a complex valuation requiring specialist expertise.
⚠️ Audit Flags
IPR&D valuation is one of the most judgment-intensive PPA components. Auditors challenge: (1) identification of which projects qualify as IPR&D (must be specific projects with commercial intent, not general research activities), (2) the MPEEM valuation assumptions (projected revenues, margins, contributory asset charges, discount rate), (3) the completion/abandonment assessment at each period-end, and (4) whether completed IPR&D projects are timely reclassified to finite-lived amortizable intangibles.
📄 Required Documentation
IPR&D project inventory at acquisition date, fair value calculation (MPEEM or alternative approach) by project, project completion probability assessment, annual impairment test, post-acquisition project status tracking (completed vs. ongoing vs. abandoned), reclassification documentation upon completion.
Professional Excel Template
Get the automated version of this entry. Includes built-in IFRS checks, VAT calculators, and SAP-ready upload formats.
Expert Analysis by Qusai Ahmad
General Accountant Supervisor & IFRS Specialist
Specialized in SAP GUI automation and Middle Eastern tax compliance. Building digital tools for the next generation of finance leaders.
Related Journal Entries
Holding Companies & Consolidations
Business Combination - Purchase Price Allocation (ASC 805) at Acquisition Date
Holding Companies & Consolidations
Goodwill - Initial Recognition and Components (Excess Purchase Price over Net Identifiable Assets)
Holding Companies & Consolidations